SG Americas Securities LLC Has $575,000 Stock Holdings in The Clorox Company (NYSE:CLX)

SG Americas Securities LLC lessened its holdings in The Clorox Company (NYSE:CLX - Free Report) by 92.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 4,036 shares of the company's stock after selling 48,390 shares during the period. SG Americas Securities LLC's holdings in Clorox were worth $575,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of CLX. Norges Bank purchased a new stake in shares of Clorox in the 4th quarter worth approximately $101,609,000. Imprint Wealth LLC lifted its position in shares of Clorox by 16,986.8% in the 2nd quarter. Imprint Wealth LLC now owns 551,392 shares of the company's stock worth $55,139,000 after purchasing an additional 548,165 shares during the period. Qube Research & Technologies Ltd lifted its position in shares of Clorox by 75.9% in the 3rd quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company's stock worth $148,161,000 after purchasing an additional 487,974 shares during the period. Acadian Asset Management LLC lifted its position in shares of Clorox by 39.6% in the 3rd quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company's stock worth $192,319,000 after purchasing an additional 415,999 shares during the period. Finally, FMR LLC lifted its position in shares of Clorox by 17.4% in the 3rd quarter. FMR LLC now owns 2,415,054 shares of the company's stock worth $316,517,000 after purchasing an additional 357,964 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Down 0.4 %

CLX traded down $0.61 during trading hours on Friday, hitting $145.94. 740,147 shares of the company's stock were exchanged, compared to its average volume of 1,233,837. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $178.21. The firm has a 50 day moving average of $151.58 and a 200 day moving average of $141.02. The firm has a market cap of $18.11 billion, a P/E ratio of 231.65, a price-to-earnings-growth ratio of 2.30 and a beta of 0.43. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The company had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.80 billion. During the same quarter in the previous year, the business posted $0.98 EPS. The firm's revenue was up 16.0% on a year-over-year basis. Analysts predict that The Clorox Company will post 5.51 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a yield of 3.29%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 761.90%.

Analyst Ratings Changes

Several equities research analysts have weighed in on CLX shares. Barclays raised their target price on shares of Clorox from $115.00 to $118.00 and gave the company an "underweight" rating in a research note on Tuesday, January 16th. Bank of America raised shares of Clorox from an "underperform" rating to a "neutral" rating and lifted their price objective for the company from $120.00 to $150.00 in a report on Friday, December 15th. DA Davidson reiterated a "neutral" rating and issued a $162.00 target price on shares of Clorox in a research report on Monday, February 5th. StockNews.com upgraded shares of Clorox from a "sell" rating to a "hold" rating in a research report on Thursday, December 7th. Finally, Jefferies Financial Group upgraded shares of Clorox from an "underperform" rating to a "hold" rating and set a $145.00 price target on the stock in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $148.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.